Using radiomics of intra-abdominal and subcutaneous adipose tissue and clinical features to predict the weight loss efficacy and remission of type 2 diabetes mellitus after bariatric surgery.
Eligibility
Sex
ALL
Min age
16 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria:
* BMI\>27.5kg/m2; Type 2 diabetes mellitus; Patients who will undergo bariatric surgery
Exclusion Criteria:
* Patients without abdominal CT scan; Patients did not undergo sleeve gastrectomy or Roux-en-Y gastric bypass.
Primary outcome measure(s)
Area under curve (AUC) of the weight loss prediction model after 1 year — 1 year This metric shows the discriminatory ability of the radiomic model to predict the probability of inadequate weight loss after 1 year.
Area under curve (AUC) of the T2DM remission prediction model after 1 year — 1 year This metric shows the discriminatory ability of the radiomic model to predict the probability of remission of T2DM after 1 year.
Trial sites (1)
Facility
City
Region
Status
Yuntao Nie
Beijing
China
Recruiting
More China-Japan Friendship Hospital trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.